Inventory / revenue moved 27336 bp lower
Inventory / revenue changed -27336 basis points from the comparable as-filed period.
330.22%→56.86%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SPAI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current ratio increased 432.9%
Current ratio changed +432.9% from the comparable as-filed period.
1.64→8.763 prior comparisons
Debt / assets moved 305 bp lower
Debt / assets changed -305 basis points from the comparable as-filed period.
4.13%→1.08%2 prior comparisons
Working capital / assets moved 6630 bp higher
Working capital / assets changed +6630 basis points from the comparable as-filed period.
14.75%→81.05%3 prior comparisons
Revenue changed across a low base
Revenue changed +1336.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$92,753→$1.3M2 prior comparisons
Receivables / revenue moved 5229 bp higher
Receivables / revenue changed +5229 basis points from the comparable as-filed period.
41.57%→93.86%2 prior comparisons
Research & development changed across a low base
Research & development changed +976.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$17,875→$192,4352 prior comparisons
Working capital changed across a low base
Working capital changed +2001.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$521,927→$11.0M3 prior comparisons
Debt / revenue moved 14645 bp lower
Debt / revenue changed -14645 basis points from the comparable as-filed period.
157.41%→10.96%1 prior comparisons
Free-cash-flow margin moved 87217 bp higher
Free-cash-flow margin changed +87217 basis points from the comparable as-filed period.
-1092.73%→-220.55%2 prior comparisons
Operating cash-flow margin moved 87368 bp higher
Operating cash-flow margin changed +87368 basis points from the comparable as-filed period.
-1089.72%→-216.04%2 prior comparisons
R&D / revenue moved 483 bp lower
R&D / revenue changed -483 basis points from the comparable as-filed period.
19.27%→14.45%2 prior comparisons
Capex / revenue moved 151 bp higher
Capex / revenue changed +151 basis points from the comparable as-filed period.
3.00%→4.51%2 prior comparisons
Trade receivables changed across a low base
Trade receivables changed +3142.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$38,559→$1.3M3 prior comparisons
Gross profit changed across a low base
Gross profit changed +2602.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$31,557→$852,8122 prior comparisons
Capital expenditure changed across a low base
Capital expenditure changed +2057.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$2,787→$60,1363 prior comparisons
Gross debt unchangedd 0.0%
Gross debt changed +0.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$146,000→$146,0004 prior comparisons
Reported total debt unchangedd 0.0%
Reported total debt changed +0.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$146,000→$146,0004 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.